Zoom Talk: Movement Disorders Group
This talk is being presented by the DMCBH movement disorders group. Vesna Sossi will discuss new insights into Parkinson's disease coming from novel analysis methods applied to PET and multimodality imaging...
Stay up-to-date with all of the life science events taking place in Vancouver with the Science in Vancouver events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Vancouver.
If you’re interested in promoting a life science event in our calendar, please use our event submission form.
This talk is being presented by the DMCBH movement disorders group. Vesna Sossi will discuss new insights into Parkinson's disease coming from novel analysis methods applied to PET and multimodality imaging...
This talk is being presented by the DMCBH movement disorders group. Vesna Sossi will discuss new insights into Parkinson's disease coming from novel analysis methods applied to PET and multimodality imaging...
This talk is being presented by the DMCBH movement disorders group. Vesna Sossi will discuss new insights into Parkinson's disease coming from novel analysis methods applied to PET and multimodality imaging...
This talk is being presented by the DMCBH movement disorders group. Vesna Sossi will discuss new insights into Parkinson's disease coming from novel analysis methods applied to PET and multimodality imaging...
This talk is being presented by the DMCBH movement disorders group. Vesna Sossi will discuss new insights into Parkinson's disease coming from novel analysis methods applied to PET and multimodality imaging...
Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anticancer immunotherapeutics such as checkpoint modulation, adoptive cell therapy,...
Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anticancer immunotherapeutics such as checkpoint modulation, adoptive cell therapy,...
Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anticancer immunotherapeutics such as checkpoint modulation, adoptive cell therapy,...
Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anticancer immunotherapeutics such as checkpoint modulation, adoptive cell therapy,...
Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anticancer immunotherapeutics such as checkpoint modulation, adoptive cell therapy,...